News

The company has reported total revenues of E1.04 billion for 2008, an increase of 4.5%, compared to E993.8 million for 2007. Jean-Luc Belingard, chairman and CEO of Ipsen,

The decrease in net loss for the fourth quarter of 2008 is due primarily to a 45% decrease in operating expenses to $2.1 million from $3.9 million in

According to the company, the Waterlase MD Turbo offers significant upgrades, including a new handpiece with newly released software that recently received 510(k) clearance from the FDA. Other

Formal notice was received by Emergency Filtration Products (EFP) on February 26, 2009. Applied Nanoscience is a marketer and developer of nanotechnology-based filtration products to customers worldwide and

The company said that it is in negotiations to acquire a pharmacy in the Florida area to execute a definitive agreement regarding the pending acquisition of the pharmacy

Under the terms of the agreement, Novartis will pay Epistem an upfront cash payment of $4 million and will provide research funding for two years. Novartis has an

As part of the agreement, Beckman Coulter has the right to deliver up to 37.5% of the purchase price in the form of Beckman Coulter stock. Correspondingly, Beckman

The experimental work has been performed in collaboration with Christophe Baudouin from the Quinze-Vingts National Ophthalmology Hospital and Science Faculty of Paris V, France. According to the company,

The company has entered into a purchase agreement with certain affiliated funds of Special Situations Funds to raise $2 million from the private placement of two million newly